﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>9</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2019</Year>
        <Month>06</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Protective Effects of Pyruvic Acid Salt Against Lithium Toxicity and Oxidative Damage in Human Blood Mononuclear Cells</ArticleTitle>
    <FirstPage>302</FirstPage>
    <LastPage>306</LastPage>
    <ELocationID EIdType="doi">10.15171/apb.2019.035</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Evgenii</FirstName>
        <LastName>Plotnikov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4374-6422</Identifier>
      </Author>
      <Author>
        <FirstName>Innokenty</FirstName>
        <LastName>Losenkov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7458-2179</Identifier>
      </Author>
      <Author>
        <FirstName>Elena</FirstName>
        <LastName>Epimakhova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9304-4496</Identifier>
      </Author>
      <Author>
        <FirstName>Nikolay</FirstName>
        <LastName>Bohan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1052-855X</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/apb.2019.035</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>09</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: Aim of present work was to study cytoprotective properties of lithium pyruvate, as a prospective pharmacological agent. Pyruvate has a lot of potential benefits due to positive influence on cell metabolism. Lithium is "gold-standard" mood-stabilizer. Combination of both may lead advantages. Methods: Lithium pyruvate was tested as cytoprotector on human blood mononuclears under induced oxidative stress. Cells were obtained from healthy donors and patients with alcoholism. The detection of cell viability, apoptosis and determination of oxidative stress level were conducted by flow cytometry. Results: Lithium pyruvate showed excellent cytoprotective properties in normal and oxidation conditions. This effect was independent from cell donor health status. It was shown on cells from healthy donors and alcoholics patients. Conclusion: Obtained results allow considering lithium pyruvate as potential normothymic agents (mood stabilizer) with excellent cytoprotective properties.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Apoptosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Antioxidant</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Oxidative stress</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Lithium pyruvate</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cytoprotection</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mood-stabilizer</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>